price-target

Ignite It
2 min read • February 7, 2020

Aurora Cannabis Analyst Welcomes Restructuring, But Sales Trends Are ‘Disappointing’

Ignite It
1 min read • February 7, 2020

Cantor Fitzgerald Maintains Overweight on Aurora Cannabis, Lowers Price Target to C$3.75

Ignite It
2 min read • February 4, 2020

BofA Sees Blockbuster Sales Potential For GW Pharma’s CBD Drug Epidiolex

Ignite It
2 min read • January 23, 2020

Analyst Raises Price Objectives For Cannabis Stocks: ‘Higher Multiples Raise The Bar For All’

Ignite It
2 min read • January 16, 2020

GW Pharma Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year

Ignite It
2 min read • January 14, 2020

Aphria’s Q2 Cannabis Sales Exceed Cantor Fitzgerald’s Expectations

Ignite It
1 min read • January 10, 2020

Piper Sandler Downgrades Aurora Cannabis to Underweight, Lowers Price Target to $1

Ignite It
1 min read • January 9, 2020

Piper Sandler Downgrades Aurora Cannabis From Neutral To Underweight, Cuts Price Target From $3 To $1

Ignite It
1 min read • December 23, 2019

UPDATE: MKM Maintains Sell On Aurora Cannabis, Lowers Tgt To C$2.00 Notes ‘The sudden departure, during a period of insider selling, dwindling cash to cover payables (Captain’s Log Volume 9), and sector turmoil does not send a strong message to investors’

Ignite It
1 min read • December 23, 2019

MKM Partners Maintains Sell on Aurora Cannabis, Lowers Price Target to C$2

Ignite It
1 min read • December 16, 2019

Craig-Hallum Initiates Coverage On Trulieve Cannabis with Buy Rating, Announces $20 Price Target

Ignite It
2 min read • December 9, 2019

Canopy Growth Analyst Says Constellation Brands Likely To Bid On Cannabis Company’s Equity

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis clubs
 cannabis cultivation
 cannabis earnings
 cannabis farms
 cannabis study
 CBD
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 germany cannabis
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 hemp rules
 Hot
 IgniteIt Events
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM
 WNBA

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.